Shell Asset Management CO Neogenomics Inc Transaction History
Shell Asset Management CO
- $2.9 Billion
- Q2 2025
A detailed history of Shell Asset Management CO transactions in Neogenomics Inc stock. As of the latest transaction made, Shell Asset Management CO holds 3,714 shares of NEO stock, worth $23,843. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,714
Previous 4,132
10.12%
Holding current value
$23,843
Previous $39,000
30.77%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding NEO
# of Institutions
284Shares Held
127MCall Options Held
942KPut Options Held
172K-
Black Rock Inc. New York, NY19.7MShares$126 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.3MShares$91.5 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny6.72MShares$43.1 Million0.04% of portfolio
-
First Light Asset Management, LLC Edina, MN6.04MShares$38.8 Million7.36% of portfolio
-
Janus Henderson Group PLC London, X05.74MShares$36.9 Million0.03% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $808M
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...